Siraigo Pharma Private Limited

ARISTO at a Glance.... Revenues ( RS. IN CRS. ) : 5700.38 Market Share : 2.90% Gain in Market Share% : -0.12% Rx Audit Rank (SMSRC) MAT March’25 : 5 Growth : 3.47% CAGR (5 years) : 10.76% Rank in Indian Pharma Market : 11 Covered Market Growth% : 6.73% Market Share in Covered Market : 6.15% Rank in Covered Market : 3 Front Line Sales Force : 5100 Source : Stockist Secondary Audit IMS - MAT MAR'25 Dataset ARISTO has been consistently growing faster than the Indian Pharma Market. This makes us the 3rd largest company in the product segments where we have our presence (IQVIA Feb’25, covered market data). Having grown consistently year over year, we have reached the league of top ten Indian owned pharma organisations by turnover (IQVIA March’25). We have achieved this distinction despite operating with only 7 marketing divisions to promote our product portfolio. On the prescription front, we are ranked 5th (SMSRC prescription audit MAT Apr’24 - Feb’25) which reflects the trust that the medical fraternity has in us. ARISTO believes in building and nurturing brands to a leadership position in respective segments. The efforts in this direction have made ten brands feature in the coveted top 300 brands of the Indian Pharma Market. Right since its inception, ARISTO has believed in introducing well differentiated formulations backed by its innovative R&D team. As a result, till date, ARISTO has the distinction of introducing over 21 formulations for the first time in India. We take pride in our infrastructure and capabilities in manufacturing and technology. We have state of the art cGMP compliant manufacturing facilities at 4 strategic locations spread over the country. The dosage forms include tablets, hard gelatin capsules, oral powders, oral liquids, dry powder injections, liquid injections, eye care preparations, creams, ointments and lotions. These facilities conform to world-class quality in design, equipment and operations. They comply with the stringent requirements of both Indian and various international regulatory agencies. Besides approvals from Indian regulatory authorities, we are proud of the fact that our facilities are also approved by international regulatory bodies like TFDA- Tanzania, PPB- Kenya, NMPB- Sudan, SBDMA- Yemen, NDA- Uganda, FMHACA- Ethiopia, MOH- Iraq and DPM- Ivory Coast. To ensure strict compliance of quality, we perform periodic review of our systems, practices and documentation across all the manufacturing facilities through regular audits. These facilities support our operations in India, Nepal and over 25 countries where we have market presence. The facilities are strategically located in North, East, West and Central India, which is of immense advantage in distribution of our finished products to our 22 Branches/distribution centers that take care of our pan-India operations.